• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病足溃疡中多重耐药菌感染的流行:一项荟萃分析。

Prevalence of multidrug-resistant bacterial infections in diabetic foot ulcers: A meta-analysis.

机构信息

Department of Endocrinology, The Bethune International Peace Hospital, Shijiazhuang, China.

Department of Orthopaedics, The Gucheng County Hospital of Hebei Province, Gucheng, China.

出版信息

Int Wound J. 2024 Apr;21(4):e14864. doi: 10.1111/iwj.14864.

DOI:10.1111/iwj.14864
PMID:38619084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11017433/
Abstract

Multidrug-resistant (MDR) bacterial infections have become increasingly common in recent years due to the increased prevalence of diabetic foot ulcers (DFUs). We carried out a meta-analysis aimed at investigating the prevalence of MDR bacteria isolated from DFUs and analysing the risk factors for MDR bacterial infection in patients with DFUs. The PubMed/Medline, Web of Science, Embase, Cochrane Library, Ovid, Scopus, and ProQuest databases were searched for studies published up to November 2023 on the clinical outcomes of MDR bacteria in DFUs. The main outcome was the prevalence of MDR bacteria in DFUs. A total of 21 studies were included, representing 4885 patients from which 2633 MDR bacterial isolates were obtained. The prevalence of MDR bacteria in DFUs was 50.86% (95% confidence interval (CI): 41.92%-59.78%). The prevalence of MDR gram-positive bacteria (GPB) in DFUs was 19.81% (95% CI: 14.35%-25.91%), and the prevalence of MDR gram-negative bacteria (GNB) in DFUs was 32.84% (95% CI: 26.40%-39.62%). MDR Staphylococcus aureus (12.13% (95% CI: 8.79%-15.91%)) and MDR Enterococcus spp. (3.33% (95% CI: 1.92%-5.07%)) were the main MDR-GPB in DFUs. MDR Escherichia coli, MDR Pseudomonas aeruginosa, MDR Enterobacter spp., MDR Klebsiella pneumoniae, and MDR Proteus mirabilis were the main MDR-GNB in DFUs. The prevalence rates were 6.93% (95% CI: 5.15%-8.95%), 6.01% (95% CI: 4.03%-8.33%), 3.59% (95% CI: 0.42%-9.30%), 3.50% (95% CI: 2.31%-4.91%), and 3.27% (95% CI: 1.74%-5.21%), respectively. The clinical variables of diabetic foot ulcer patients infected with MDR bacteria and non-MDR bacteria in the included studies were analysed. The results showed that peripheral vascular disease, peripheral neuropathy, nephropathy, osteomyelitis, Wagner's grade, previous hospitalization and previous use of antibacterial drugs were significantly different between the MDR bacterial group and the non-MDR bacterial group. We concluded that there is a high prevalence of MDR bacterial infections in DFUs. The prevalence of MDR-GNB was greater than that of MDR-GPB in DFUs. MDR S. aureus was the main MDR-GPB in DFUs, and MDR E. coli was the main MDR-GNB in DFUs. Our study also indicated that peripheral vascular disease, peripheral neuropathy, nephropathy, osteomyelitis, Wagner's grade, previous hospitalization, and previous use of antibacterial drugs were associated with MDR bacterial infections in patients with DFUs.

摘要

近年来,由于糖尿病足溃疡(DFU)的患病率增加,多药耐药(MDR)细菌感染变得越来越普遍。我们进行了一项荟萃分析,旨在调查从 DFU 分离的 MDR 细菌的患病率,并分析 DFU 患者中 MDR 细菌感染的危险因素。检索了截至 2023 年 11 月在 PubMed/Medline、Web of Science、Embase、Cochrane Library、Ovid、Scopus 和 ProQuest 数据库上发表的关于 MDR 细菌在 DFU 中临床结局的研究。主要结局是 DFU 中 MDR 细菌的患病率。共纳入 21 项研究,代表了 4885 名患者,从中获得了 2633 株 MDR 细菌分离株。DFU 中 MDR 细菌的患病率为 50.86%(95%置信区间:41.92%-59.78%)。DFU 中 MDR 革兰阳性菌(GPB)的患病率为 19.81%(95%置信区间:14.35%-25.91%),DFU 中 MDR 革兰阴性菌(GNB)的患病率为 32.84%(95%置信区间:26.40%-39.62%)。MDR 金黄色葡萄球菌(12.13%(95%置信区间:8.79%-15.91%))和 MDR 肠球菌属(3.33%(95%置信区间:1.92%-5.07%))是 DFU 中主要的 MDR-GPB。MDR 大肠埃希菌、MDR 铜绿假单胞菌、MDR 肠杆菌属、MDR 肺炎克雷伯菌和 MDR 奇异变形杆菌是 DFU 中主要的 MDR-GNB。患病率分别为 6.93%(95%置信区间:5.15%-8.95%)、6.01%(95%置信区间:4.03%-8.33%)、3.59%(95%置信区间:0.42%-9.30%)、3.50%(95%置信区间:2.31%-4.91%)和 3.27%(95%置信区间:1.74%-5.21%)。对纳入研究中感染 MDR 细菌和非 MDR 细菌的糖尿病足溃疡患者的临床变量进行了分析。结果表明,MDR 细菌组与非 MDR 细菌组在周围血管疾病、周围神经病变、肾病、骨髓炎、Wagner 分级、既往住院和既往使用抗菌药物方面差异有统计学意义。我们得出结论,DFU 中存在 MDR 细菌感染的高患病率。DFU 中 MDR-GNB 的患病率大于 MDR-GPB。MDR 金黄色葡萄球菌是 DFU 中主要的 MDR-GPB,MDR 大肠埃希菌是 DFU 中主要的 MDR-GNB。我们的研究还表明,周围血管疾病、周围神经病变、肾病、骨髓炎、Wagner 分级、既往住院和既往使用抗菌药物与 DFU 患者的 MDR 细菌感染有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/2fdfd3b62266/IWJ-21-e14864-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/5a3660e2a438/IWJ-21-e14864-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/6adc59594d76/IWJ-21-e14864-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/ef971a6e40cd/IWJ-21-e14864-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/97cc26586c53/IWJ-21-e14864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/7162a2e9851c/IWJ-21-e14864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/6374a089e713/IWJ-21-e14864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/2fdfd3b62266/IWJ-21-e14864-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/5a3660e2a438/IWJ-21-e14864-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/6adc59594d76/IWJ-21-e14864-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/ef971a6e40cd/IWJ-21-e14864-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/97cc26586c53/IWJ-21-e14864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/7162a2e9851c/IWJ-21-e14864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/6374a089e713/IWJ-21-e14864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/11017433/2fdfd3b62266/IWJ-21-e14864-g007.jpg

相似文献

1
Prevalence of multidrug-resistant bacterial infections in diabetic foot ulcers: A meta-analysis.糖尿病足溃疡中多重耐药菌感染的流行:一项荟萃分析。
Int Wound J. 2024 Apr;21(4):e14864. doi: 10.1111/iwj.14864.
2
Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.采用微生物检测方法,对肯尼亚糖尿病足溃疡患者进行细菌分离及抗生素敏感性检测,并与逆转录聚合酶链反应(RT-PCR)检测金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌(MRSA)的结果进行比较。
BMC Res Notes. 2019 Apr 29;12(1):244. doi: 10.1186/s13104-019-4278-0.
3
Microbial Profile and Antibiotic Susceptibility Pattern in Diabetic Patients with Mild, Moderate, and Severe Foot Infections in Tehran.德黑兰轻、中、重度糖尿病足感染患者的微生物谱及抗生素药敏模式。
Arch Razi Inst. 2022 Oct 31;77(5):1925-1933. doi: 10.22092/ARI.2022.359759.2476. eCollection 2022 Oct.
4
Bacteriological analysis and antibiotic resistance in patients with diabetic foot ulcers in Dhaka.达卡糖尿病足溃疡患者的细菌学分析及抗生素耐药性
PLoS One. 2024 May 17;19(5):e0301767. doi: 10.1371/journal.pone.0301767. eCollection 2024.
5
Inflammatory markers as risk factors for infection with multidrug-resistant microbes in diabetic foot subjects.炎症标志物作为糖尿病足患者感染多重耐药微生物的危险因素。
Foot (Edinb). 2017 Aug;32:44-48. doi: 10.1016/j.foot.2017.05.001. Epub 2017 May 3.
6
Microbiological Features and Risk Factors in Patients With Diabetic Foot Ulcers.糖尿病足溃疡患者的微生物学特征及危险因素
Wounds. 2015 Nov;27(11):308-12.
7
Assessment of the Risk Factors of Multidrug-Resistant Organism Infection in Adults With Type 1 or Type 2 Diabetes and Diabetic Foot Ulcer.成人 1 型或 2 型糖尿病合并糖尿病足溃疡患者中多重耐药菌感染的危险因素评估。
Can J Diabetes. 2020 Jun;44(4):342-349. doi: 10.1016/j.jcjd.2019.10.009. Epub 2019 Nov 9.
8
Infection Characteristics and Drug Susceptibility of Multidrug-Resistant Bacteria in Patients with Diabetic Foot Ulcers.糖尿病足溃疡患者的多重耐药菌感染特征及药敏分析。
Clin Lab. 2023 Sep 1;69(9). doi: 10.7754/Clin.Lab.2023.230309.
9
Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection.糖尿病足感染中多重耐药菌的危险因素分析。
BMC Endocr Disord. 2022 Feb 21;22(1):46. doi: 10.1186/s12902-022-00957-0.
10
Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.多药耐药和毒力生物体创伤感染:创伤感染性疾病结局研究倡议。
Mil Med. 2022 May 4;187(Suppl 2):42-51. doi: 10.1093/milmed/usab131.

引用本文的文献

1
Epidemiology, Risk Factors, and External Validation of Predictive Models for Multidrug-Resistant Bacterial Infections in Diabetic Foot Ulcers.糖尿病足溃疡多重耐药菌感染预测模型的流行病学、危险因素及外部验证
Infect Drug Resist. 2025 Aug 28;18:4471-4483. doi: 10.2147/IDR.S537142. eCollection 2025.
2
Photocatalysis and Photodynamic Therapy in Diabetic Foot Ulcers (DFUs) Care: A Novel Approach to Infection Control and Tissue Regeneration.糖尿病足溃疡(DFUs)护理中的光催化与光动力疗法:一种感染控制和组织再生的新方法
Molecules. 2025 May 26;30(11):2323. doi: 10.3390/molecules30112323.
3
Multidrug resistance, biofilm formation, and genetic determinants in diabetic foot infections from Uttar Pradesh, India: a clinical-microbiological insight from a prospective study.

本文引用的文献

1
Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis.糖尿病足溃疡患者中多重耐药菌感染的分布及耐药危险因素分析:一项回顾性研究
PeerJ. 2023 Oct 9;11:e16162. doi: 10.7717/peerj.16162. eCollection 2023.
2
Infection Characteristics and Drug Susceptibility of Multidrug-Resistant Bacteria in Patients with Diabetic Foot Ulcers.糖尿病足溃疡患者的多重耐药菌感染特征及药敏分析。
Clin Lab. 2023 Sep 1;69(9). doi: 10.7754/Clin.Lab.2023.230309.
3
Distribution of microbes and antimicrobial susceptibility in patients with diabetic foot infections in South China.
印度北方邦糖尿病足感染中的多重耐药性、生物膜形成及遗传决定因素:一项前瞻性研究的临床微生物学见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 23. doi: 10.1007/s00210-025-04284-8.
4
Clinical efficacy of antibiotic-loaded bone cement and negative pressure wound therapy in multidrug-resistant organisms diabetic foot ulcers: a retrospective analysis.载抗生素骨水泥与负压伤口治疗对耐多药菌糖尿病足溃疡的临床疗效:一项回顾性分析
Front Cell Infect Microbiol. 2025 Jan 3;14:1521199. doi: 10.3389/fcimb.2024.1521199. eCollection 2024.
5
[Nine-year trend in Escherichia coli resistance to ciprofloxacin: cross-sectional study in a hospital in Colombia].[大肠杆菌对环丙沙星耐药性的九年趋势:哥伦比亚一家医院的横断面研究]
Cad Saude Publica. 2024 Aug 26;40(7):e00031723. doi: 10.1590/0102-311XES031723. eCollection 2024.
6
Which test(s) can best identify the causative pathogen(s) and result in tailored use of antibiotics?哪种检测能够最好地识别致病病原体并实现抗生素的针对性使用?
Int Wound J. 2024 Jul;21(7):e14958. doi: 10.1111/iwj.14958.
中国南方地区糖尿病足感染患者的微生物分布及药敏情况。
Front Endocrinol (Lausanne). 2023 Jan 24;14:1113622. doi: 10.3389/fendo.2023.1113622. eCollection 2023.
4
Identification and antibiotic susceptibility of microorganisms isolated from diabetic foot ulcers: A pathological aspect.从糖尿病足溃疡分离出的微生物的鉴定及抗生素敏感性:病理学视角
Exp Ther Med. 2022 Dec 7;25(1):53. doi: 10.3892/etm.2022.11752. eCollection 2023 Jan.
5
Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia.来自埃塞俄比亚亚的斯亚贝巴选定医院的糖尿病足溃疡细菌分离株及其抗菌药物耐药谱。
Front Endocrinol (Lausanne). 2022 Aug 31;13:987487. doi: 10.3389/fendo.2022.987487. eCollection 2022.
6
Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.多重耐药菌:作用机制与预防。
Biomed Res Int. 2022 Sep 5;2022:5419874. doi: 10.1155/2022/5419874. eCollection 2022.
7
Microbial Infection and Antibiotic Susceptibility of Diabetic Foot Ulcer in China: Literature Review.中国糖尿病足溃疡的微生物感染与抗生素耐药性:文献综述。
Front Endocrinol (Lausanne). 2022 May 19;13:881659. doi: 10.3389/fendo.2022.881659. eCollection 2022.
8
Distribution and drug sensitivity of pathogenic bacteria in diabetic foot ulcer patients with necrotizing fasciitis at a diabetic foot center in China.中国糖尿病足中心坏疽性筋膜炎合并糖尿病足溃疡患者病原菌分布及药敏分析。
BMC Infect Dis. 2022 Apr 22;22(1):396. doi: 10.1186/s12879-022-07382-7.
9
Risk Factors for Multidrug-Resistant Organisms Infection in Diabetic Foot Ulcer.糖尿病足溃疡中多重耐药菌感染的危险因素
Infect Drug Resist. 2022 Apr 7;15:1627-1635. doi: 10.2147/IDR.S359157. eCollection 2022.
10
Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection.糖尿病足感染中多重耐药菌的危险因素分析。
BMC Endocr Disord. 2022 Feb 21;22(1):46. doi: 10.1186/s12902-022-00957-0.